Q-omics provides the consensus-scored RPL23AP54 profile across patient tissues and cancer cell-line models. RPL23AP54 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, RPL23AP54 RNA expression shows 3,286 significant pathway-activity associations, with the highest sampling consensus in LUSC. Together, these results highlight HNSC, and LUSC as cancer lineages where RPL23AP54 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.